![Kevin Finney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Finney
Director/Board Member at
VAXART, INC.
Net worth: 131 852 $ as of 2026-07-30
Profile
Kevin P.
Finney was the founder of Zavante Therapeutics, Inc., founded in 2015, where the title held was Chief Operating Officer from 2015 to 2018.
Current jobs include Chairman, President & Chief Executive Officer at Autobahn Therapeutics, Inc. since 2019; Vice Chairman at Eirion Therapeutics, Inc. since 2016; and Independent Director at Vaxart, Inc. starting in 2025.
Former jobs include Chairman at Elsie Biotechnologies Inc. from 2021 to 2024; Director at Anterios, Inc. from 2015 to 2016; Director at TARIS BioMedical LLC from 2015 to 2019; President, Chief Operating Officer & Director at Abide Therapeutics, Inc. in 2019; and Head-World Wide Corporate Development at Allergan, Inc. from 2006 to 2015.
Education includes undergraduate studies at The California State University and an MBA from Pepperdine Graziadio Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VAXART, INC. 0.1% | 2026-07-15 | 244,171 ( 0.1% ) | 131 852 $ | 2026-07-30 |
Kevin Finney active positions
| Companies | Position | Start |
|---|---|---|
| VAXART, INC. | Director/Board Member | 2025-01-27 |
Eirion Therapeutics, Inc.
 Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription products for medical dermatology and aesthetic medicines | Director/Board Member | 2015-12-31 |
Autobahn Therapeutics, Inc.
 Autobahn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops medications for the treatment of central nervous system (CNS) disorders | Chief Executive Officer | 2019-10-31 |
Former positions of Kevin Finney
| Companies | Position | End |
|---|---|---|
Elsie Biotechnologies Inc.
 Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Chairman | 2024-05-31 |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Director/Board Member | 2019-11-30 |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | President | 2019-06-30 |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Founder | 2018-08-31 |
Anterios, Inc.
 Anterios, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops botulinum products for therapeutic and aesthetic applications | Director/Board Member | 2015-12-31 |
Training of Kevin Finney
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops botulinum products for therapeutic and aesthetic applications | Health Technology |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Health Technology |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Health Technology |
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zavante Therapeutics, Inc.
Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Eirion Therapeutics, Inc.
Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription products for medical dermatology and aesthetic medicines | Health Technology |
Pepperdine Graziadio Business School
 Pepperdine Graziadio Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autobahn Therapeutics, Inc.
Autobahn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops medications for the treatment of central nervous system (CNS) disorders | Health Technology |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Health Technology |
- Stock Market
- Insiders
- Kevin Finney
